Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Pamart, Thibault"" wg kryterium: Autor


Wyświetlanie 1-8 z 8
Tytuł :
Feasibility and safety of transfemoral transcatheter aortic valve implantation performed with a percutaneous coronary intervention-like approach.
Autorzy :
Denimal, Tom
Delhaye, Cédric
Piérache, Adeline
Robin, Emmanuel
Modine, Thomas
Moussa, Mouhamed
Sudre, Arnaud
Koussa, Mohamad
Debry, Nicolas
Pamart, Thibault
Lamblin, Nicolas
Lemesle, Gilles
Spillemaeker, Hugues
Verdier, Basile
Porouchani, Sina
Cosenza, Alessandro
Bical, Antoine
Schurtz, Guillaume
Labreuche, Julien
Ternacle, Julien
Pokaż więcej
Źródło :
Archives of Cardiovascular Diseases; Aug2021, Vol. 114 Issue 8/9, p537-549, 13p
Czasopismo naukowe
Tytuł :
Balloon aortic valvuloplasty for severe aortic stenosis before urgent non-cardiac surgery.
Autorzy :
Debry N; CHU Lille, Institut Coeur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Lille, France.
Altes A
Vincent F
Delhaye C
Schurtz G
Nedjari F
Legros G
Porouchani S
Coisne A
Richardson M
Cosenza A
Verdier B
Denimal T
Pamart T
Spillemaeker H
Sylla H
Sudre A
Janah D
Aouate D
Marsou W
Appert L
Lemesle G
Labreuche J
Maréchaux S
Van Belle E
Pokaż więcej
Źródło :
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology [EuroIntervention] 2021 Oct 01; Vol. 17 (8), pp. e680-e687. Date of Electronic Publication: 2021 Oct 01.
Typ publikacji :
Journal Article
MeSH Terms :
Aortic Valve Stenosis*/surgery
Balloon Valvuloplasty*
Transcatheter Aortic Valve Replacement*/adverse effects
Aortic Valve/diagnostic imaging ; Aortic Valve/surgery ; Humans ; Retrospective Studies ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.
Autorzy :
Van Belle E; CHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Manigold T; CHU Nantes, Nantes, France.
Piérache A; Département de Biostatistiques, Univ. Lille, CHU Lille, ULR 2694 - METRICS: évaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France.
Furber A; Cardiologie, CHU Angers, France.
Debry N; CH Saint-Philibert, Lille, France.
Luycx-Bore A; CH Beauvais, Beauvais, France.
Bauchart JJ; Clinique la Louvière, Lille, France.
Nugue O; Centre hospitalier Boulogne, France.
Huchet F; CH Saint-Nazaire, France.
Bic M; CH Lens, France.
Vinchon F; CH Le Mans, France.
Sayah S; CH Creil, France.
Fournier A; CHU Amiens, France.
Decoulx E; CH Roubaix, France.
Mouhammad U; CH Valenciennes, France.
Clerc J; CH Compiègne, France.
Manchuelle A; Clinique Bois Bernard, France.
Lazizi T; CH Laval, France.
Chmait A; Clinique Côte d'Opale, Saint-Martin Boulogne, France.
Jeannetteau J; Clinique Saint-Joseph, Angers, France.
Hénon P; CH Saint-Quentin, France, France.
Bonin M; CHU Nantes, Nantes, France.
Dupret-Minet M; CH Dunkerque, France, France.
Tirouvanziam A; Polyclinique du Confluent, Nantes, France.
Molcard D; CH Soissons, France.
Arabucki F; CH La Roche Sur Yon, France.
Py A; Clinique Victor Pauchet, Amiens, France.
Prunier F; Cardiologie, CHU Angers, France.
Delhaye C; CHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Lemesle G; CHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Schurtz G; CHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Cosenza A; CHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Spillemaeker H; CHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Verdier B; CHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Denimal T; CHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Pamart T; CHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Sylla H; CHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Janah D; CHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Aouate D; CHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Porouchani S; CHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Guillez V; CHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Bonnet G; Hôpital Cardiologique Haut-Lévêque, CHU de Bordeaux, 33600 Pessac, France.
Ternacle J; Hôpital Cardiologique Haut-Lévêque, CHU de Bordeaux, 33600 Pessac, France.
Labreuche J; Département de Biostatistiques, Univ. Lille, CHU Lille, ULR 2694 - METRICS: évaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France.
Cayla G; CHU Nîmes, France.
Vincent F; CHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Pokaż więcej
Źródło :
The Lancet regional health. Europe [Lancet Reg Health Eur] 2021 Mar; Vol. 2, pp. 100030. Date of Electronic Publication: 2021 Jan 13.
Typ publikacji :
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies